JP Morgan Chase’s SYMMETRY MEDICAL INC SMA Stock Holding History

JP Morgan Chase’s Portfolio SMA Stock Details SMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-575,850	Closed	-$5.81M	–	4533
2014 Q3	$5.81M	Buy	575,850 +30,123	+6%	+$279K	﹤0.01%	2265
2014 Q2	$4.83M	Buy	545,727 +112,912	+26%	+$984K	﹤0.01%	2085
2014 Q1	$4.35M	Buy	432,815 +145,787	+51%	+$1.45M	﹤0.01%	2164
2013 Q4	$2.89M	Sell	287,028 -5,770	-2%	-$50.2K	﹤0.01%	2518
2013 Q3	$2.39M	Buy	292,798 +15,633	+6%	+$132K	﹤0.01%	2689
2013 Q2	$2.33M	Buy	+277,165	New	+$2.85M	﹤0.01%	2705

JP Morgan Chase's SMA Position: Q4 2014 in Review

JP Morgan Chase sold out of SYMMETRY MEDICAL INC (SMA) in Q4 2014, closing a stake of 575,850 shares — an estimated $5.81M sold.

JP Morgan Chase first reported a position in SMA in Q2 2013 and held it in 6 quarters. The position peaked at $5.81M in Q3 2014. 0 funds tracked by Wall St. Rank hold SMA as of Q4 2014.

JP Morgan Chase reported no remaining SYMMETRY MEDICAL INC position as of Q4 2014 after selling out during the quarter.
JP Morgan Chase sold 575,850 SYMMETRY MEDICAL INC shares in Q4 2014, an estimated $5.81M.
JP Morgan Chase first reported a position in SYMMETRY MEDICAL INC in Q2 2013 and held it in 6 quarters.
JP Morgan Chase's SYMMETRY MEDICAL INC position peaked at $5.81M in Q3 2014.
0 funds tracked by Wall St. Rank held SYMMETRY MEDICAL INC as of Q4 2014.

Based on JP Morgan Chase's 13F filing for Q4 2014, filed 13 Feb 2015.